SWB NHS Trust's Transformation and Research Award goes to Dr Shivan Pancham, City Hospital Birmingham

Dr Shivan Pancham, Consultant Haematologist was recognised by Sandwell and West Birmingham NHS Trust (SWB) for the wonderful work she does in promoting research and transformation for the red cell disorders community.  Congratulations Dr Pancham! 

..
Dr P Award RN Dr P

Click on the following link where you can watch a short YouTube clip of one of SWB's research nurses discussing why this award was so well deserved: https://www.youtube.com/watch?v=YCCl0YbUgAg. You can also read more about the staff recognition event here: https://www.swbh.nhs.uk/media/nhs-heroes-take-home-the-trophies-2/

BBC News Article: Jenica Leah's Children's Books

Jenica Leah

Click on the following link to be taken to the BBC's website where you can read a news article about Birmingham woman Jenica Leah who has written a series of children's books to help raise awareness of sickle cell:  https://www.bbc.co.uk/news/uk-england-birmingham-63129471

New sickle cell treatment given to first patients in England

Image showing a vial of crizanlizumab

 

Sickle cell patients have begun receiving the first new treatment for the blood disorder in over 20 years.

The inherited condition can cause severe pain and organ failure, often requiring hospital admissions.

Crizanlizumab is given as a monthly infusion and is thought to cut visits to A&E by 40%.

Sickle cell patients have begun receiving the first new treatment for the blood disorder in over 20 years.

A patient who received the treatment at Birmingham City Hospital, having suffered repeated periods of intense pain for decades.

These are called sickle cell crises and are common in people with the condition.

"To have a crisis is pain beyond what you could ever experience," Patient says.

"They give you a scale of one to 10 - but it is way beyond that."

Sickle cell disease causes red blood cells to distort and become sticky, blocking vessels and restricting oxygen supply, which triggers excruciating pain.

Crizanlizumab, a monoclonal antibody, binds to a protein on blood cells, preventing them from clumping.

Sickle cell mostly affects black people.

To read the full article on the BBC website please click this link

Do you have any questions?
Please click on the button on the far right of this message to be directed to our contact form

Contact Us